Risk factors
Neonc Technologies Holdings (NTHI) risk factors
Item 1A of every Neonc Technologies Holdings, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors74 risks
NeonC Technologies Holdings operates as a clinical-stage biopharmaceutical company focused on oncology product candidates NEO100 and NEO212, facing substantial recurring operating losses and going concern doubts.
Filed Mar 31, 2026